NHNSENarayana Hrudayalaya Ltd.· Healthcare ServicesHighNeutral
Announced Fri, 12 Dec, 2025 · 20:34 IST

Board approves demerger of Clinical Services from NHIC into NHL

Nclt Scheme FiledStrategic Transactions View source PDFExplain this filing

NH · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+1.9%Reaction day
₹1870.00
prior close
₹1863.00
announcement price
After-mkt
timing
Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)+0.4%+1.6% vs market
Hospital peers, median of 21sector+0.3%+1.7% vs sector

On the reaction day the stock moved 1.6 pts more than Nifty Smallcap 250 and 1.7 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.4
10m
+0.0
15m
+0.1
30m
+0.4
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+1.9+0.4+1.6+0.3+1.7
Next day
+1.3-0.4+1.7-0.4+1.7
2d
+0.4-1.1+1.5-1.3+1.6
3d
-1.7-1.2-0.5-2.5+0.8
4d
+2.7+0.1+2.6-2.3+5.0
5d
+1.3+1.0+0.3-1.7+3.0
1w
+0.3+1.5-1.2-1.8+2.1
15d
+3.7+2.4+1.3-2.9+6.6
1m
+2.4-1.2+3.6-7.3+9.7
2m
-2.1-2.5+0.5-10.1+8.1
3m
-12.0-9.7-2.3-17.5+5.5
UpDownMarket · Nifty Smallcap 250Sector · Hospital peers, median of 21Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Narayana Hrudayalaya board approved a scheme to demerge the Clinical Services business (10 clinics in Bengaluru) from wholly-owned subsidiary NH Integrated Care into itself. The unit had FY25 revenue of Rs 39.94 crore (1.11% of NHL standalone turnover). No cash or shares will be issued since NHIC is a wholly-owned subsidiary. The Aarogyam preventive healthcare arm stays with NHIC. Scheme needs NCLT and other approvals.

Likely market impact

Internal group restructuring; no cash or share consideration, so no immediate impact on NHL shareholders. Subject to NCLT and other regulatory approvals before becoming effective.